3Chou AJ, Geller DS, Gorlick R. Therapy for osteosarcoma: where do we go from here? [ J ] . Paediatr Drugs, 2008, 10(5):315-327. 被引量：1
4Goodman LS, Wintrobe MM, Dameshek W, et al. Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders [ J ] . JAMA, 1984, 251(17):2255- 2261. 被引量：1
5Evans AE. Mitomycin C [ J ] . Cancer Chemother Rep, 1961, 14:1-9. 被引量：1
6Sullivan MP, Taylor G. L-Phenylalanine mustard as a treatment for metastatic osteogenie sarcoma in children [ J ] . J Pediatr, 1963, 63:227-237. 被引量：1
7Cortes EP, Holland JF, Wang JJ, et al. Doxorubicin in disseminated osteosarcoma [J]. JAMA, 1972, 221(10):1132-1138. 被引量：1
8Cortes EP, Holland JF, Wang JJ, et al. Doxorubicin in disseminated osteosarcoma[J]. JAMA, 1972, 221(10):1132-1138. 被引量：1
9Jaffe N. Recent advances in the chemotherapy of metastatic osteogenic sarcoma [ J ] . Cancer, 1972, 30(6): 1627-1631. 被引量：1
10Rosen G, Marcove RC, Caparros B, et al. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery [ J ] . Cancer, 1979, 43(6):2163-2177. 被引量：1
